Previous 10 |
Cogent Biosciences Announces Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients at CTOS 2020 Majority of patients treated with PLX9486 + sunitinib experienced clinical benefit with a median PFS of 12 months and 20% ORR, including a complete response, in a heavi...
Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 12, 2020 CAMBRIDGE, Mass. , Nov. 12, 2020 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focuse...
Cogent Biosciences (COGT): Q3 GAAP EPS of -$5.07 misses by $4.91.Revenue of $0.31M (-69.6% Y/Y)Press Release For further details see: Cogent Biosciences EPS misses by $4.91
Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates Andrew Robbins appointed President, CEO and Director Final results from PLX9486 + sunitinib Phase 1/2 study in GIST patients selected for oral presentation at Connective Tissue Onc...
Cogent Biosciences to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 5, 2020 CAMBRIDGE, Mass. , Nov. 5, 2020 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focu...
Gainers: DBV Technologies (DBVT) +61%, AnPac Bio-Medical Science (ANPC) +16%, Community Health Systems (CYH) +15%, ProPhase Labs (PRPH) +12%, ZIOPHARM Oncology (ZIOP) +10%.Losers: Liquidia Technologies (LQDA) -28%, Jounce Therapeutics (JNCE) -...
Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer Seasoned executive with deep experience developing precision medicines for genetically defined diseases, most recently as COO of Array Biopharma PR Newswire CAMBRIDGE, Mass., Oct. 26, 2020 CA...
News, Short Squeeze, Breakout and More Instantly...
Cogent Biosciences Inc Com Company Name:
COGT Stock Symbol:
NASDAQ Market:
Cogent Biosciences Inc Com Website:
2024-07-06 14:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WALTHAM, Mass. and BOULDER, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced it has reached alignment with the U.S. Food and Drug Admin...
2024-06-26 16:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...